Allakos ALLK 深 沪
已收盘 05-15 16:00:00 美东时间
0.3291
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.3291
- 总市值 2974.31万
- 52周最高 1.555
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.2157
- 委 比 0.00%
- 总股本 9037.70万
- 历史最高 157.98
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.2157
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Allakos Completes Merger with Concentra Biosciences
Allakos ( ($ALLK) ) has provided an announcement. On May 15, 2025, Allakos Inc....
2025-05-15 21:49
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, HMST, ALLK, OPOF on Behalf of Shareholders
NEW YORK, April 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-04-05 00:42
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Allakos (NASDAQ:ALLK) stock rose 48.2% to $0.32 during Wednesday's reg...
2025-04-03 01:06
Allakos Announces Merger Agreement with Concentra Biosciences
Allakos ( ($ALLK) ) has shared an update. On April 1, 2025, Allakos Inc. entere...
2025-04-02 20:49
Allakos Reports Q4 2024 Results Amid Strategic Shift
Allakos ( ($ALLK) ) has released its Q4 earnings. Here is a breakdown of the in...
2025-03-14 12:14
Allakos GAAP EPS of $0.00
Allakos press release (NASDAQ:ALLK): Q4 GAAP EPS of $0.00. Allakos ended the fourth quarter of 2024 with $80.8 million in cash, cash equivalents and investments resulting in a net decrease in cash, ca...
2025-03-13 05:00
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.
2025-02-01 03:20
Why Is Allakos Stock Plunging On Monday?
Allakos halts AK006 development after phase 1 trial disappoints. Restructuring includes workforce cuts and $34 million-$38 million in estimated costs.
2025-01-28 03:05
Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Allakos (ALLK)
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
2025-01-28 01:30
BUZZ-Allakos falls over 70% after halting development of skin condition drug
** Drug developer Allakos' ALLK.O shares fall 72.7% to 33 cents premarket ** Co says its experimental drug, AK006, did not show clinical benefit in an early-stage trial testing it in patients with chr...
2025-01-27 21:08
